Effectiveness of a web-based self-help tool to reduce problem gambling: A randomized controlled trial.

comorbidity online problem gambling randomized controlled trial self-help tool web

Journal

Journal of behavioral addictions
ISSN: 2063-5303
Titre abrégé: J Behav Addict
Pays: Hungary
ID NLM: 101602037

Informations de publication

Date de publication:
05 Oct 2023
Historique:
received: 19 12 2022
revised: 06 06 2023
revised: 26 07 2023
accepted: 30 07 2023
medline: 1 11 2023
pubmed: 2 9 2023
entrez: 2 9 2023
Statut: epublish

Résumé

Problem gambling constitutes a public health concern associated with psychopathological comorbidity, substance use, and financial difficulties. Most individuals with gambling problems avoid counseling services due to perceived stigma and their preference for self-reliance. Treatment accessibility could be improved through web-based interventions. We recruited 360 individuals with gambling problems and randomized them to a web-based intervention (n = 185) or an active control group consisting of a self-help manual for problem gambling (n = 175). The primary outcome was the number of days of gambling in the last 30 days. Secondary outcomes included money spent in the last 30 days, time gambling in the last 7 days, gambling-related problems, consumption of alcohol and cigarettes, and psychopathological comorbidity measured at posttreatment and 6-month follow-up. The primary outcome decreased significantly for both groups, with no significant difference between the groups. There were significant group × time interactions according to the Gambling Symptom Assessment Scale (F = 8.83, p <0 .001), the Problem Gambling Severity Index (F = 3.54, p = 0.030), for cigarettes smoked in the last 7 days (F = 26.68, p < 0.001), the Patient Health Questionnaire-9 (F = 19.41, p <0 .001), and the Generalized Anxiety Disorder-7 (F = 41.09, p <0 .001) favoring the intervention group. We experienced an overall high dropout rate (76%). Win Back Control seems to be an effective low-threshold treatment option for individuals with gambling problems that might otherwise be unapproachable for outpatient treatment services. Nevertheless, the high dropout rate should be considered when interpreting the study results, as they may have introduced a degree of variability.

Sections du résumé

Background and Aims UNASSIGNED
Problem gambling constitutes a public health concern associated with psychopathological comorbidity, substance use, and financial difficulties. Most individuals with gambling problems avoid counseling services due to perceived stigma and their preference for self-reliance. Treatment accessibility could be improved through web-based interventions.
Methods UNASSIGNED
We recruited 360 individuals with gambling problems and randomized them to a web-based intervention (n = 185) or an active control group consisting of a self-help manual for problem gambling (n = 175). The primary outcome was the number of days of gambling in the last 30 days. Secondary outcomes included money spent in the last 30 days, time gambling in the last 7 days, gambling-related problems, consumption of alcohol and cigarettes, and psychopathological comorbidity measured at posttreatment and 6-month follow-up.
Results UNASSIGNED
The primary outcome decreased significantly for both groups, with no significant difference between the groups. There were significant group × time interactions according to the Gambling Symptom Assessment Scale (F = 8.83, p <0 .001), the Problem Gambling Severity Index (F = 3.54, p = 0.030), for cigarettes smoked in the last 7 days (F = 26.68, p < 0.001), the Patient Health Questionnaire-9 (F = 19.41, p <0 .001), and the Generalized Anxiety Disorder-7 (F = 41.09, p <0 .001) favoring the intervention group. We experienced an overall high dropout rate (76%).
Conclusions UNASSIGNED
Win Back Control seems to be an effective low-threshold treatment option for individuals with gambling problems that might otherwise be unapproachable for outpatient treatment services. Nevertheless, the high dropout rate should be considered when interpreting the study results, as they may have introduced a degree of variability.

Identifiants

pubmed: 37659086
doi: 10.1556/2006.2023.00045
pmc: PMC10562826
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

744-757

Auteurs

Nikolaos Boumparis (N)

1Swiss Research Institute for Public Health and Addiction, University of Zurich, Zurich, Switzerland.

Christian Baumgartner (C)

1Swiss Research Institute for Public Health and Addiction, University of Zurich, Zurich, Switzerland.

Doris Malischnig (D)

2Institute for Addiction Prevention, Addiction and Drug Coordination Vienna, Austria.

Andreas Wenger (A)

1Swiss Research Institute for Public Health and Addiction, University of Zurich, Zurich, Switzerland.

Sophia Achab (S)

3Department of Psychiatry, Faculty of Medicine, Clinical and Sociological Research Unit, University of Geneva, Switzerland.
4Department of Psychiatry, Treatment Centre ReConnecte, Addiction Division, University Hospitals of Geneva, Switzerland.

Yasser Khazaal (Y)

5Addiction Medicine, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
6Department of Psychiatry and Addiction, Montreal University, Montreal, Canada.

Matthew T Keough (MT)

7Department of Psychology, York University, Toronto, ON, Canada.

David C Hodgins (DC)

8University of Calgary, Calgary, Canada.

Elena Bilevicius (E)

9Department of Psychology, University of Manitoba, Winnipeg, Manitoba, Canada.

Alanna Single (A)

9Department of Psychology, University of Manitoba, Winnipeg, Manitoba, Canada.

Severin Haug (S)

1Swiss Research Institute for Public Health and Addiction, University of Zurich, Zurich, Switzerland.

Michael P Schaub (MP)

1Swiss Research Institute for Public Health and Addiction, University of Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH